

Sukaar Welfare Organization is a non-governmental, non-profit community development organization based in Sindh Province, Pakistan. It was established by a group of young community development professionals, human rights activists, researchers, and concerned citizens with a shared commitment to promoting sustainable development for marginalized and underserved communities. The organization works to reduce poverty and contribute to a more secure, equitable, and prosperous society by empowering vulnerable populations through inclusive and participatory approaches.
As a grassroots advocacy organization, Sukaar Welfare Organization focuses on advancing Sexual and Reproductive Health and Rights (SRHR), alongside broader themes of human rights, gender equality, and community empowerment. The organization actively engages in awareness-raising, capacity building, and stakeholder mobilization to address systemic inequalities and improve access to essential services.
Hepatitis prevention and response is a key cross-cutting thematic area within the organization’s work. Through advocacy, community awareness campaigns, and mass mobilization efforts, Sukaar Welfare Organization collaborates with relevant stakeholders to promote prevention, early detection, and improved access to care. This focus is particularly critical in Sindh, where hepatitis C remains a major public health challenge, with significant gaps in awareness, screening, and treatment among underserved populations.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close